You Searched For "serum institute ceo" and got 20 results
Sort By:
4 mins read
Reliance, Tata on TIME's list of world's most influential companies
Serum Institute is the other Indian company on the list. TIME listed Reliance in the 'Tita…
PTI
2 mins read
Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate
The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunis…
PTI
1 min read
DGCI allows Serum Institute to export malaria vaccine to UK
The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of th…
PTI
2 mins read
India to launch its first indigenously developed cervical cancer vaccine in the next few months
Cervical cancer ranks as the 2nd most prevalent cancers in India and accounts for nearly one-fou…
2 mins read
Global rollout of 12 billion Covid-19 vaccine doses largest-ever, but access is an issue: WHO
Addressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network …
1 min read
Serum Institute to roll out COVID-19 vaccine for children in six months, says CEO Adar Poonawalla
"We haven't seen a lot of severe disease in children. Fortunately, the panic is not there fo…
PTI
3 mins read
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
2 mins read
Oxford COVID-19 vaccine: SII pauses trials in India following show-cause notice
"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. W…
3 mins read
India has its eyes and hopes pinned on Adar Poonawalla— the world’s biggest vaccine maker who will be speaking at the Global Trends Festival 2020
If developing a vaccine for COVID-19 virus is the most important thing, the 39-year old Adar Poonaw…
1 min read
Serum Institute applies to Indian authorities for full market authorisation of Covishield
SII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine t…
PTI
4 mins read
COVID-19 vaccine will be priced at ₹1,000 and would be available by February for healthcare workers and elderly people, says Serum CEO Adar Poonawalla
"It will probably take two or three years for every Indian to get inoculated, not just because o…
PTI
1 min read
Serum Institute CEO says vaccine development is like rollercoaster
"Developing a vaccine is like riding a rollercoaster; there are plenty of ups and downs. Sometim…
2 mins read
SII CEO believes 'vaccine nationalism' in India and the US could derail efforts to deliver two billion doses to poorer nations
Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries…
1 min read
Serum Institute seeks EUA for its Covovax vaccine for 12-17 yrs age group
In the application for emergency use authorisation (EUA) for the 12-17 year age group, Prakash Kuma…
PTI
2 mins read
Around 10 crore doses of Covishield to be manufactured and supplied in June, says Serum Institute of India
In a recent letter to Union Home Minister Amit Shah, SII said its employees have been working …
PTI
2 mins read
Serum Institute claims that its COVID vaccine is safe and that it has a clean chit from the authorities for Covishield
The Serum Institute of India (SII) claims it has a clean chit from the authorities and that its COV…
2 mins read
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion
In addition to vaccines, the strategic alliance will also develop antibodies targeting seve…
PTI
3 mins read
Madras High Court issues notice to Centre and five other respondents over Covishield vaccine's side effects on volunteer
The Madras High court on Friday issued a notice to the Centre and five other respondents including …
1 min read
Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September
Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …
3 mins read
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…